63323-771-39 · Azacitidine Injection · Fresenius Kabi USA, LLC
What is the status for 63323-771-39 · Azacitidine Injection · Fresenius Kabi USA, LLC?
For 63323-771-39, generic name is Azacitidine Injection; manufacturer is Fresenius Kabi USA, LLC; status is Current; availability now is Unavailable; fda note is Discontinuation of the manufacture of the drug, recorded from its source on 2026-11-04.
"initial_posting_date": "12/18/2020", "package_ndc": "63323-771-39", "generic_name": "Azacitidine Injection", "contact_info": "1-888-386-1300", "availability": "Unavailable", "related_info": "Discontinuation of the manufacture of the drug"
— api.fda.gov, retrieved 2026-11-04
- Package NDC
- 63323-771-39 verified
- Generic name
- Azacitidine Injection verified
- Manufacturer
- Fresenius Kabi USA, LLC verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Discontinuation of the manufacture of the drug verified
- Initial posting date
- 12/18/2020 verified
- Last update date
- 11/03/2026 verified
- Days in shortage
- 2147 our reading
- Reason for shortage
- Discontinuation of the manufacture of the drug verified
- Dosage form
- Injection verified
- Therapeutic category
- Oncology verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "11/03/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39)", "company_name": "Fresenius Kabi USA, LLC", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current"
— all from api.fda.gov, retrieved 2026-11-04
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000